Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Sales (2020 - 2025)

Historic Return on Sales for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 0.33%.

  • Treace Medical Concepts' Return on Sales rose 100.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.27% for FY2024, which is 0.0% changed from last year.
  • Per Treace Medical Concepts' latest filing, its Return on Sales stood at 0.33% for Q3 2025, which was up 100.0% from 0.37% recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Return on Sales high stood at 0.01% for Q4 2024, and its period low was 0.48% during Q2 2024.
  • In the last 5 years, Treace Medical Concepts' Return on Sales had a median value of 0.31% in 2022 and averaged 0.28%.
  • In the last 5 years, Treace Medical Concepts' Return on Sales tumbled by -3000bps in 2021 and then skyrocketed by 1300bps in 2023.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Return on Sales stood at 0.2% in 2021, then skyrocketed by 59bps to 0.08% in 2022, then decreased by -26bps to 0.1% in 2023, then skyrocketed by 91bps to 0.01% in 2024, then tumbled by -3521bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.37% for Q2 2025, and 0.31% during Q1 2025.